Effectiveness and safety of elbasvir/grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim, In Hee Kim, Byung Seok Lee, Youn Jae Lee, Woo Jin Chung, Sook-Hyang Jeong
Korean J Intern Med. 2021;36(Suppl 1):S1-S8. Published online 2020 Jun 17 DOI: https://doi.org/10.3904/kjim.2019.357
Citations to this article as recorded by 
A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
Ethan M. Balk, Gaelen P. Adam, Michel Jadoul, Paul Martin, Craig E. Gordon
Kidney International Reports.2023; 8(2): 240. CrossRef
Elbasvir/grazoprevir
Reactions Weekly.2023; 1938(1): 583. CrossRef
A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
Hye-Lin Kim, Kyung-Ah Kim, Gwang Hyun Choi, Eun Sun Jang, Moran Ki, Hwa Young Choi, Sook-Hyang Jeong
Clinical and Molecular Hepatology.2022; 28(1): 91. CrossRef